CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of $90.94 billion. The enterprise value is $160.29 billion.
| Market Cap | 90.94B |
| Enterprise Value | 160.29B |
Important Dates
The next estimated earnings date is Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Apr 23, 2026 |
Share Statistics
CVS Health has 1.27 billion shares outstanding. The number of shares has increased by 0.71% in one year.
| Current Share Class | 1.27B |
| Shares Outstanding | 1.27B |
| Shares Change (YoY) | +0.71% |
| Shares Change (QoQ) | +0.63% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 89.92% |
| Float | 1.27B |
Valuation Ratios
The trailing PE ratio is 51.42 and the forward PE ratio is 9.97. CVS Health's PEG ratio is 0.89.
| PE Ratio | 51.42 |
| Forward PE | 9.97 |
| PS Ratio | 0.23 |
| Forward PS | 0.22 |
| PB Ratio | 1.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.65 |
| P/OCF Ratio | 8.55 |
| PEG Ratio | 0.89 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.96, with an EV/FCF ratio of 20.53.
| EV / Earnings | 90.66 |
| EV / Sales | 0.40 |
| EV / EBITDA | 10.96 |
| EV / EBIT | 16.00 |
| EV / FCF | 20.53 |
Financial Position
The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.06.
| Current Ratio | 0.84 |
| Quick Ratio | 0.57 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | 4.53 |
| Debt / FCF | 10.24 |
| Interest Coverage | 3.21 |
Financial Efficiency
Return on equity (ROE) is 2.29% and return on invested capital (ROIC) is 5.62%.
| Return on Equity (ROE) | 2.29% |
| Return on Assets (ROA) | 2.47% |
| Return on Invested Capital (ROIC) | 5.62% |
| Return on Capital Employed (ROCE) | 6.08% |
| Weighted Average Cost of Capital (WACC) | 5.10% |
| Revenue Per Employee | $1.33M |
| Profits Per Employee | $5,893 |
| Employee Count | 300,000 |
| Asset Turnover | 1.58 |
| Inventory Turnover | 18.56 |
Taxes
In the past 12 months, CVS Health has paid $408.00 million in taxes.
| Income Tax | 408.00M |
| Effective Tax Rate | 19.10% |
Stock Price Statistics
The stock price has increased by +5.26% in the last 52 weeks. The beta is 0.46, so CVS Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +5.26% |
| 50-Day Moving Average | 77.57 |
| 200-Day Moving Average | 74.12 |
| Relative Strength Index (RSI) | 32.00 |
| Average Volume (20 Days) | 8,482,478 |
Short Selling Information
The latest short interest is 17.58 million, so 1.38% of the outstanding shares have been sold short.
| Short Interest | 17.58M |
| Short Previous Month | 20.35M |
| Short % of Shares Out | 1.38% |
| Short % of Float | 1.38% |
| Short Ratio (days to cover) | 1.67 |
Income Statement
In the last 12 months, CVS Health had revenue of $399.83 billion and earned $1.77 billion in profits. Earnings per share was $1.39.
| Revenue | 399.83B |
| Gross Profit | 53.13B |
| Operating Income | 10.02B |
| Pretax Income | 2.14B |
| Net Income | 1.77B |
| EBITDA | 14.63B |
| EBIT | 10.02B |
| Earnings Per Share (EPS) | $1.39 |
Balance Sheet
The company has $10.60 billion in cash and $79.95 billion in debt, with a net cash position of -$69.35 billion or -$54.51 per share.
| Cash & Cash Equivalents | 10.60B |
| Total Debt | 79.95B |
| Net Cash | -69.35B |
| Net Cash Per Share | -$54.51 |
| Equity (Book Value) | 75.38B |
| Book Value Per Share | 59.18 |
| Working Capital | -13.98B |
Cash Flow
In the last 12 months, operating cash flow was $10.64 billion and capital expenditures -$2.83 billion, giving a free cash flow of $7.81 billion.
| Operating Cash Flow | 10.64B |
| Capital Expenditures | -2.83B |
| Depreciation & Amortization | 4.61B |
| Net Borrowing | -1.78B |
| Free Cash Flow | 7.81B |
| FCF Per Share | $6.14 |
Margins
Gross margin is 13.29%, with operating and profit margins of 2.51% and 0.44%.
| Gross Margin | 13.29% |
| Operating Margin | 2.51% |
| Pretax Margin | 0.53% |
| Profit Margin | 0.44% |
| EBITDA Margin | 3.66% |
| EBIT Margin | 2.51% |
| FCF Margin | 1.95% |
Dividends & Yields
This stock pays an annual dividend of $2.66, which amounts to a dividend yield of 3.72%.
| Dividend Per Share | $2.66 |
| Dividend Yield | 3.72% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 191.37% |
| Buyback Yield | -0.71% |
| Shareholder Yield | 3.01% |
| Earnings Yield | 1.94% |
| FCF Yield | 8.59% |
Analyst Forecast
The average price target for CVS Health is $94.72, which is 32.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $94.72 |
| Price Target Difference | 32.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 4.29% |
| EPS Growth Forecast (5Y) | 52.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CVS Health has an Altman Z-Score of 2.27 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.27 |
| Piotroski F-Score | 7 |